Minimally Invasive Surgery Market was valued over US$ 8.7 Bn in 2020 and is projected to expand at a moderate CAGR from 2021 to 2031, favorable reimbursement scenario, and rise in cancer awareness & patient support programs by governments are anticipated to propel the market